Investing Profile

Florian Müllershausen

InvestorVC
Managing Director at Novartis Venture Fund
nvfund.comBasel, Switzerland
Photo of Florian Müllershausen, Managing Director at Novartis Venture Fund
Your Intro Paths to Florian Müllershausen

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Florian is a member of
Novartis Network
82 CONNECTIONS
Novartis Network
82 CONNECTIONS
Novartis Network
82 CONNECTIONS
Novartis Network
82 CONNECTIONS
Novartis Network
82 CONNECTIONS

Find Florian Müllershausen on

cb
Current Investing Position
Novartis Venture Fund Managing Director
Investment Range
$5.0M - $10.0M
Sweet Spot
$7.5M
Investments On Record
13
Current Fund Size
$750M

Florian Müllershausen is on these Sector & Stage Rankings

Florian Müllershausen's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Artios Pharma
Series DNov 2025$120M
Series CJul 2021$150M
Series BAug 2018$83M
$380M
Co-investors: René Kuijten (EQT Group), Raphael Wisniewski (Andera Partners), Barbara Dalton (SROne), Hakan Goker (MDC Ventures (formerly KBS Ventures)), Nikola Trbovic (SV Health Investors), Jake Simson (RA Capital Management)
NRG Therapeutics
Series BSep 2025$68M
$86M
Co-investors: Jonathan Tobin (Brandon Capital Partners), Laurence Barker (SV Health Investors' Dementia Discovery Fund (DDF))
FoRx Therapeutics
Series AJun 2025$49M
SeedApr 2020$11M
$110M
Co-investors: Vincent Brichard (EQT Group), Therese Liechtenstein (MDC Ventures (formerly KBS Ventures)), Vincent Ossipow (Omega Funds), Denis Patrick (Pfizer Venture Investments)
Rhygaze
Series AJan 2025$86M
SeedJul 2024$11M
$97M
Co-investors: David Schenkein (GV (Google Ventures)), Daniela Couto (BGV (BioGeneration Ventures))
Citryll
Series BDec 2024$90M
$110M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures)), Isabelle de Cremoux (Seventure Partners), Geert-Jan Mulder (Forbion)
LOQUS23 THERAPEUTICS
Series AOct 2024$46M
SeedNov 2021$9M
$55M
Co-investors: Rogier Rooswinkel (Hotmail)
Amphista Therapeutics
Series BMar 2021$53M
$61M
Co-investors: Satish Jindal (Advent Life Sciences), Raj Parekh (Advent Life Sciences), Rogier Rooswinkel (Hotmail)
Anaveon
Series AFeb 2019$35M
$160M
Co-investors: Jasper Bos (Forbion), Ohad Hammer (Pontifax Venture Capital), Denis Patrick (Pfizer Venture Investments)

Florian Müllershausen's Experience

Postdoc Girls Who CodePresent
Postdoc Ruhr-Universität Bochum, Institute for PharmacologyPresent
Postdoc NovartisPresent
Laboratory Head - Investigator II NovartisPresent
Project Team Head - Investigator III, Translational Medicine Associate Autoimmunity NovartisPresent
Translational Medicine Expert - Senior Investigator I, Autoimmunity NovartisPresent
Translational Medicine Expert - Senior Investigator II - Autoimmunity NovartisPresent
Scientific Manager, Board Office NovartisPresent
Principal Girls Who CodePresent
Principal Novartis Venture FundPresent
Managing Director Girls Who CodePresent
Managing Director Novartis Venture FundPresent

Florian Müllershausen's Education

Ruhr University Bochum Dr. rer. nat. (PhD)
Freie Universität Berlin Diploma (eq. to MSc
Freie Universität Berlin Diploma (eq. to MSc Biochemistry
Ruhr University Bochum Dr. rer. nat. (PhD) Molecular Pharmacology
Ruhr-Universität Bochum Dr. rer. nat. (PhD) Molecular Pharmacology

Investors who invest with Florian Müllershausen

Sign in with Google →

Scouts & Angels Affiliated With Florian Müllershausen

Sign in with Google →